This course has expired. View available courses.
Endocrinology
Examining the cardiorenal benefits of SGLT2 inhibitors for people with type 2 diabetes
In recent landmark trials, certain SGLT2 inhibitors have demonstrated cardiovascular and renal benefits in patients with type 2 diabetes.
This video helps clinicians navigate the most recent clinical evidence for SGLT2 inhibitors and reviews the updated recommendations from the Diabetes Canada guidelines. The goal is to help clinicians apply the cardiorenal evidence to primary care practice and increase their confidence in identifying patients who would benefit from SGLT2i and initiating SGLT2i in those patients.
This program has received an educational grant or in-kind support from Astra Zeneca.
DURATION
30 mins
PROFESSION
Physician
# OF CREDITS
0.25
ACCREDITATION
Mainpro+
EXPIRY DATE
2022-09-27
In recent landmark trials, certain SGLT2 inhibitors have demonstrated cardiovascular and renal benefits in patients with type 2 diabetes.
This video helps clinicians navigate the most recent clinical evidence for SGLT2 inhibitors and reviews the updated recommendations from the Diabetes Canada guidelines. The goal is to help clinicians apply the cardiorenal evidence to primary care practice and increase their confidence in identifying patients who would benefit from SGLT2i and initiating SGLT2i in those patients.
This program has received an educational grant or in-kind support from Astra Zeneca.
Faculty
Louis Girard, MD, MBT, FRCPC
Peter J. Lin, MD, CCFP
Christine Palmay, Hons BArt+Sci, MD, CCFP
Phuongbich Nguyen, MD
Learning objectives
After viewing this expert brief video, participants will be better able to:
- Describe the cardiovascular and renal risks associated with type 2 diabetes
- Discuss the cardiovascular and renal outcome results of SGLT2 inhibitors in clinical trials and their relevance to primary care practice
- Recommend SGLT2 inhibitors that have demonstrated cardiorenal protection in clinical trials and are in line with the recommendations from Diabetes Canada guidelines
Accreditation
Cert+ Program ID#: 194412
#
of credits: 0.25
Duration: 30 mins
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
